K2 Principal Fund, L.P. Merck & Co., Inc. Transaction History
K2 Principal Fund, L.P.
- $307 Million
- Q4 2024
A detailed history of K2 Principal Fund, L.P. transactions in Merck & Co., Inc. stock. As of the latest transaction made, K2 Principal Fund, L.P. holds 13,032 shares of MRK stock, worth $1.03 Million. This represents 0.42% of its overall portfolio holdings.
Number of Shares
13,032Holding current value
$1.03 Million% of portfolio
0.42%Shares
1 transactions
Others Institutions Holding MRK
# of Institutions
3,954Shares Held
1.86BCall Options Held
16MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA251MShares$19.9 Billion0.45% of portfolio
-
Black Rock Inc. New York, NY207MShares$16.4 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$9.57 Billion0.49% of portfolio
-
Geode Capital Management, LLC Boston, MA61.2MShares$4.84 Billion0.48% of portfolio
-
Morgan Stanley New York, NY44.2MShares$3.5 Billion0.32% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $201B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...